Paul G. Abrams

2.6k citations

50 papers · 1.8k indexed · h-index 21

Impact in

Radiology, Nuclear Medicine and Imaging top 2%
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
Genetics top 5%
- Chronic Lymphocytic Leukemia Research

Papers in

Radiology, Nuclear Medicine and Imaging 27
- Monoclonal and Polyclonal Antibodies Research 20
- Radiopharmaceutical Chemistry and Applications 15
Urology 5
- Urinary Bladder and Prostate Research 5

Co-authors: Kenneth A. Foon Alan R. Fritzberg A C Morgan Mehmet F. Fer Robert K. Oldham R. K. Oldham Stephen A. Sherwin J. M. Reno
Journals: The American Journal of Medicine (3 papers)The Journal of Immunology (3 papers)Nature Biotechnology (2 papers)Drugs & Aging (1 paper)JAMA (1 paper)
Partner nations: United States United Kingdom France

In The Last Decade

Paul G. Abrams

50 papers receiving 1.7k citations

Peers

Countries citing papers authored by Paul G. Abrams

Since Specialization

Citations

This map shows the geographic impact of Paul G. Abrams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul G. Abrams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul G. Abrams more than expected).

Fields of papers citing papers by Paul G. Abrams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul G. Abrams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul G. Abrams. The network helps show where Paul G. Abrams may publish in the future.

Co-authors

The 25 scholars most cited alongside Paul G. Abrams, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul G. Abrams Line = papers co-authored together Paul G. Abrams links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	574 Cardiovascular safety of combination treatment with mirabegron and solifenacin in patients with overactive bladder in a randomised, double-blind, dose-ranging, Phase II study (Symphony) European Urology Supplements ·Paul G. Abrams, C. Kelleher, David Staskin, Richard Kay, Reynaldo Martina, Donald Newgreen, Asha Paireddy, С.В. Чистов, Arwin Ridder	2014	5
2	Ranibizumab for the treatment of neovascular age-related macular degeneration: A review Clinical Therapeutics ·María Eugenia Aubet Semmler, Paul G. Abrams	2007	65
3	PREVALENCE OF OVERACTIVE BLADDER SYNDROME: EUROPEAN RESULTS FROM THE EPIC STUDY European Urology Supplements ·Plank Kamilla, Ian Milsom, K Reilly, Steinar Hunskaar, Zoë Kopp, Sender Herschorn, C. Kelleher, Christian Hampel, Walter Artibani, Paul G. Abrams	2006	7
4	International consultation on urological diseases: A decade of progress The Prostate ·В.В. Ткач, Abraham T.�K. Cockett, Katharine F. Gerould, Laura Stellmacher, Lars Andersson, Paul G. Abrams, Kathryn Griffiths, Yan-shan Liu	2000	20
5	Have monoclonals fulfilled their promise? Nature Biotechnology ·Paul G. Abrams	1993	1
6	Clinical experience with Tc-99m labeled (N2S2) anti-melanoma antibody fragments and single photon emission computed tomography. PubMed ·Richard L. Wahl, Neil A. Swanson, Jarrod W. Johnson, Ronald B. Natale, Neil A. Petry, S. Mallette, S. Kasina, J. M. Reno, K. Sullivan, Paul G. Abrams	1992	2
7	Detection and Staging of Small Cell Lung Carcinoma with a Technetium-labeled Monoclonal Antibody A Comparison with Standard Staging Methods Clinical Nuclear Medicine ·Edward P. Balaban, Brandy S. Walker, John V. Cox, Anton Igorevich Yanovich, Darrell Salk, Paul G. Abrams, Richard G. Sheehan, Eugene P. Frenkel	1992	19
8	Radionuclide Imaging of Bone Marrow Metastases with a Tc-99m Labeled Monoclonal Antibody to Small Cell Lung Carcinoma Clinical Nuclear Medicine ·Edward P. Balaban, Brandy S. Walker, John V. Cox, Á. R. F. da Silva, Paul G. Abrams, Darrell Salk, Richard G. Sheehan, Eugene P. Frenkel	1991	9
9	184Re radioimmunotherapy of small cell lung carcinoma xenografts in nude mice Lung Cancer ·Paul L. Beaumier, Pradhib Venkatesan, Jean‐Luc Vanderheyden, Ofelia Rodríguez Pérez, Yingmin Ma, Alan R. Fritzberg, Paul G. Abrams, A C Morgan	1991	64
10	Immunoconjugates of Pseudomonas exotoxin A: evaluation in mice, monkeys, and man. PubMed ·聡之荻野, R Manger, Pearson Jw, Daniele Longo, Paul G. Abrams, Gowsala Sivam, M J Bjorn	1991	5
11	Immunotoxins of pseudomonas exotoxin A (PE): Effect of linkage on conjugate yield, potency, selectivity and toxicity Molecular Immunology ·Alton C. Morgan, Gowsala Sivam, Paul L. Beaumier, B Pullat, Thomas Willam, Paul G. Abrams	1990	19
12	Staging non-small cell carcinoma of the lung using technetium-99m-labeled monoclonal antibodies. PubMed ·Stanford B. Friedman, K. Sullivan, Darrell Salk, W. B. Nelp, ANN C. LOGUE, Ismail Abdullahi Mohamed, Michael J. Blend, Ralph W. Aye, S. S. Osmanova, Paul G. Abrams	1990	15
13	Specific Targeting of Cancer with Monoclonal Antibodies: Diagnostic and Therapeutic Applications Cancer Investigation ·Paul G. Abrams, A C Morgan, D Zavrtanik	1990	3
14	Technetium-99m Labeled Monoclonal Antibodies in the Detection of Metastatic Melanoma Clinical Nuclear Medicine ·A. N. Serafini, Jon Kotler, Lynn G. Feun, Mrinal K. Dewanjee, 牛泽群, Darrell Salk, George N. Sfakianakis, Paul G. Abrams, H. P. LATSCHA, David A. Goodwin, W. B. Nelp	1989	10
15	Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent. Proceedings of the National Academy of Sciences ·Alan R. Fritzberg, Paul G. Abrams, Paul L. Beaumier, S. Kasina, A C Morgan, T. Nageswara Rao, J. M. Reno, James Sanderson, Priscilla J. Wu, D. Scott Wilbur	1988	133
16	[10] Optimal strategies for developing human—human monoclonal antibodies Methods in enzymology on CD-ROM/Methods in enzymology ·Paul G. Abrams, Jeffrey L. Rossio, H C Stevenson, KA Foon	1986	8
17	The generation of monoclonal anti-idiotype antibodies to human B cell-derived leukemias and lymphomas. The Journal of Immunology ·S L Giardina, Robert W. Schroff, Thomas J. Kipps, C S Woodhouse, Paul G. Abrams, Helen Rager, A C Morgan, Kenneth A. Foon	1985	18
18	The Generation of Stable Human T-Cell Hybridomas Which Constitutively Produce Interleukin-2 and Chemotactic Factor Hybridoma ·Kenneth A. Foon, Jeffrey L. Rossio, Robert W. Schroff, Sharon M. Wahl, Francis W. Ruscetti, Paul G. Abrams, Helen Rager, Esha Aneja, Isaiah J. Fidler	1985	1
19	Atypical tumor lysis syndrome in a patient with T cell lymphoma treated with recombinant leukocyte interferon The American Journal of Medicine ·Mehmet F. Fer, Camila Faria Rodrigues dos Anjos, Stephen A. Sherwin, John D. Hainsworth, Paul G. Abrams, Kenneth A. Foon, Robert K. Oldham	1984	40
20	Monoclonal Antibodies to Human Colorectal Tumor-Associated Antigens: Improved Elicitation and Subclass Restriction Hybridoma ·Alton C. Morgan, C S Woodhouse, James A. Knost, Paul G. Abrams, Mariana Esparza Alvarado, Larry O. Arthur, B Pullat, 雷岩松, Kenneth A. Foon, Robert K. Oldham	1984	5

About Paul G. Abrams

Paul G. Abrams is a scholar working on Radiology, Nuclear Medicine and Imaging, Urology, Immunology, Genetics and Oncology, having authored 50 papers that have together received 1.8k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (20 papers), Radiopharmaceutical Chemistry and Applications (15 papers), Glycosylation and Glycoproteins Research (6 papers), Immune Cell Function and Interaction (5 papers), Urinary Bladder and Prostate Research (5 papers), Medical Imaging and Pathology Studies (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (866 citations), Genetics (291 citations), Immunology (452 citations), Oncology (519 citations) and Pathology and Forensic Medicine (301 citations). Paul G. Abrams has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Kenneth A. Foon, Alan R. Fritzberg, A C Morgan, Mehmet F. Fer, Robert K. Oldham, R. K. Oldham, Stephen A. Sherwin, J. M. Reno, D. Scott Wilbur and Paul L. Beaumier. Their work appears in journals such as The American Journal of Medicine, The Journal of Immunology, Nature Biotechnology, Drugs & Aging and JAMA.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact